Loading...

AXGN AXOGEN INC Earnings Reports 8-K Filing

XGN

XGN

AXOGEN INC

(AXGN)

2026 8-K

Quarterly Results

Stock Offering Announcement

Preliminary Financial Results

CFO Compensation Update

FDA Approval Announcement

Earnings Release

FDA Amendment Update

Financial Statements

Appointing a new CFO

Corporate Presentation

Financial Results

Financial Results

Q3 Financial Results

FDA Application Submitted

Appointment of CEO and Chai...

Earnings Reports

Annual Meeting Results

Annual Meeting and Voting R...

Earnings Reports

Resignation of Chief Resear...

Regulation FD Disclosure

Earnings Report

Corporate Presentation Update

Departure of CFO

Financial Performance and C...

Appointment of Director

Appointment of CFO

Financial Results and Corpo...

Retirement of Named Executi...

Annual Meeting of Shareholders

Financial Results and Corpo...

Agreement Amendment

Earnings Reports

Shareholder Director Nomina...

External Links:

On January 12, 2026, Axogen, Inc. announced its preliminary, unaudited financial performance for the fourth quarter and full year of 2025. The information was shared in a press release, which is available on their investor relations website.

AI Assistant

AXOGEN INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.